Clinical Trial Update: Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating paclitaxel, pembrolizumab, and olaparib in previously treated advanced gastric adenocarcinoma is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Drugs mentioned

• Olaparib (Olaparib)
• PACLITAXEL (PACLITAXEL)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Advanced Gastric Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING